The molecular logic of endocannabinoid signalling

Piomelli, Daniele·2003·Nature Reviews Neuroscience
DOI 10.1038/nrn1247

Cited by (1,006)

Items 101–200 of 1,006

  1. The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
    Miriam Melis, Saturnino Spiga, Marco Diana · 2005 · International review of neurobiology
  2. The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells
    Tania Aguado, Javier Palazuelos, Krisztina Monory, Nephi Stella, Benjamin F. Cravatt, Beat Lutz, Giovanni Marsicano, Zaal Kokaia, Manuel Guzmán, Ismael Galve‐Roperh · 2006 · Journal of Neuroscience
  3. Supply and demand for endocannabinoids
    Bradley E. Alger, Jimok Kim · 2011 · Trends in Neurosciences
  4. Brain regulation of food intake and appetite: molecules and networks
    Christian Broberger · 2005 · Journal of Internal Medicine
  5. Cannabinoid CB 2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
    Karen L. Wright, Marnie Duncan, Keith A. Sharkey · 2007 · British Journal of Pharmacology
  6. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high’
    David A. Raichlen, Adam D. Foster, Gregory L. Gerdeman, Alexandre Seillier, Andrea Giuffrida · 2012 · Journal of Experimental Biology
  7. Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling
    Azad, Shahnaz C., Monory, Krisztina, Marsicano, Giovanni, Cravatt, Benjamin F., Lutz, Beat, Zieglgänsberger, Walter, Rammes, Gerhard · 2004 · The Journal of Neuroscience
  8. Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory
    Robin, Laurie M., Oliveira da Cruz, José F., Langlais, Valentin C., Martin-Fernandez, Mario, Metna-Laurent, Mathilde, Busquets-Garcia, Arnau, Bellocchio, Luigi, Soria-Gomez, Edgar, Papouin, Thomas, Varilh, Marjorie et al. · 2018 · Neuron
  9. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1α
    Chevaleyre, Vivien, Heifets, Boris D., Kaeser, Pascal S., Südhof, Thomas C., Castillo, Pablo E. · 2007 · Neuron
  10. Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
    Cristina Blázquez, Luis González‐Feria, Luis Álvarez, Amador Haro, M. Casanova, Manuel Guzmán · 2004 · Cancer Research
  11. Cannabis use during pregnancy: Pharmacokinetics and effects on child development
    Kimberly S. Grant, Rebekah Petroff, Nina Isoherranen, Nephi Stella, Thomas M. Burbacher · 2017 · Pharmacology & Therapeutics
  12. Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome
    Dinan, Timothy G, Cryan, John F · 2017 · Neuropsychopharmacology
  13. Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
    Ahmad R. Hariri, Adam X. Gorka, Luke Williamson Hyde, Mark A. Kimak, Indrani Halder, Francesca Ducci, Robert E. Ferrell, David A Goldman, Stephen B. Manuck · 2008 · Biological Psychiatry
  14. Cannabidiol (CBD) as a Promising Anti-Cancer Drug
    Emily S. Seltzer, Andrea K. Watters, Danny MacKenzie, Lauren M. Granat, Dong Zhang · 2020 · Cancers
  15. Mechanisms in the Bed Nucleus of the Stria Terminalis Involved in Control of Autonomic and Neuroendocrine Functions: A Review
    Carlos César Crestani, Fernando H.F. Alves, Felipe V. Gomes, Leonardo B.M. Resstel, Fernando Morgan de Aguiar Corrêa, James P. Herman · 2013 · Current Neuropharmacology
  16. Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex
    Mathieu Lafourcade, Izaskun Elezgarai, Susana Mato, Yamina Bakiri, Pedro Grandes, Olivier J. Manzoni · 2007 · PLoS ONE
  17. The search for the palmitoylethanolamide receptor
    Jesse LoVerme, Giovanna La Rana, Roberto Russo, Antonio Calignano, Daniele Piomelli · 2005 · Life Sciences
  18. Synaptic lipid signaling
    Bazan, Nicolas G. · 2003 · Journal of Lipid Research
  19. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
    Ana María Martín-Moreno, Begoña Brera, Carlos Spuch, Eva Carro, Luis García‐García, Mercedes Delgado, Miguel A. Pozo, Nadia Giselle Innamorato, Antonio Cuadrado, Maria L. DE CEBALLOS · 2012 · Journal of Neuroinflammation
  20. Synaptic functions of endocannabinoid signaling in health and disease
    Alfonso Araque, Pablo E. Castillo, Olivier J. Manzoni, Raffaella Tonini · 2017 · Neuropharmacology
  21. Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
    Mario van der Stelt, Marcello Trevisani, Vittorio Vellani, Luciano De PETROCELLIS, Aniello Schiano Moriello, Barbara Campi, Peter Anthony McNaughton, Piero Geppetti, Vincenzo Di Marzo · 2005 · The EMBO Journal
  22. Downregulation of the CB1Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
    Anikó Ludányi, Lóránd Erőss, Sándor Czirják, János Vajda, Péter Halász, Masahiko Watanabe, Miklós Palkovits, Zsófia Maglóczky, Tamás F. Freund, István Katona · 2008 · Journal of Neuroscience
  23. The endocannabinoid system in brain reward processes
    Marcello Solinas, Steven R. Goldberg, Daniele Piomelli · 2008 · British Journal of Pharmacology
  24. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use
    F. Markus Leweke, Andrea Giuffrida, Dagmar Koethe, Daniela Schreiber, Brit M. Nolden, Laura Kranaster, Miriam A. Neatby, Miriam Schneider, C.W. Gerth, Martin Hellmich et al. · 2007 · Schizophrenia Research
  25. Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice
    Krisztina Monory, Heike Blaudzun, Federico Massa, Nadine Kaiser, Thomas Lemberger, Günther Schütz, Carsten Tobias Wotjak, Beat Lutz, Giovanni Marsicano · 2007 · PLoS Biology
  26. Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
    Lucía Callén, Estefanía Moreno, Pedro Barroso‐Chinea, David Moreno‐Delgado, Antoni Cortés, Josefa Mallol, Vicent Casadó, José Luis Lanciego, Rafael Franco, Carmen Lluís et al. · 2012 · Journal of Biological Chemistry
  27. Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
    Ester Aso, Isidró Ferrer · 2014 · Frontiers in Pharmacology
  28. The endocannabinoid system in anxiety, fear memory and habituation
    Sabine Ruehle, Alejandro Aparisi Rey, Floortje Remmers, Beat Lutz · 2011 · Journal of Psychopharmacology
  29. The psychiatric side-effects of rimonabant
    Fabrício A. Moreira, José Alexandre S. Crippa · 2009 · Brazilian Journal of Psychiatry
  30. Integration of Endocannabinoid and Leptin Signaling in an Appetite-Related Neural Circuit
    Young‐Hwan Jo, Ying-Jiun J. Chen, Streamson C. Chua, David A. Talmage, Lorna W. Role · 2005 · Neuron
  31. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
    Judit K. Makara, Marco Mor, Darren Fegley, Szilárd I Szabó, Satish Kathuria, Giuseppe Astarita, Andrea Duranti, Andrea Tontini, Giorgio Tarzia, Silvia Rivara et al. · 2005 · Nature Neuroscience
  32. Cannabidiol as potential anticancer drug
    Paola Massi, Marta Solinas, Valentina Cinquina, Daniela Parolaro · 2012 · British Journal of Clinical Pharmacology
  33. Synaptically Driven Endocannabinoid Release Requires Ca2+-Assisted Metabotropic Glutamate Receptor Subtype 1 to Phospholipase C β4 Signaling Cascade in the Cerebellum
    Takashi Maejima, Saori Oka, Yuki Hashimotodani, Takako Ohno‐Shosaku, Atsu Aiba, Dianqing Wu, Keizo Waku, Takayuki Sugiura, Masanobu Kano · 2005 · Journal of Neuroscience
  34. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats
    Marcello Solinas, Zuzana Justinová, Steven R. Goldberg, Gianluigi Tanda · 2006 · Journal of Neurochemistry
  35. RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol
    T. P. Dinh, Satish Kathuria, Daniele Piomelli · 2004 · Molecular Pharmacology
  36. Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
    Haibin Wang, Sudhansu K. Dey, Mauro Maccarrone · 2006 · Endocrine Reviews
  37. Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior
    Chen-Jie Shen, Di Zheng, Kexin Li, Jian‐Ming Yang, Haoqi Pan, Xiao-Dan Yu, Jiayu Fu, Yi Zhu, Qi-Xin Sun, Mengyu Tang et al. · 2019 · Nature Medicine
  38. Endocannabinoid system and mood disorders: Priming a target for new therapies
    Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, Carsten Tobias Wotjak, Filippo Drago · 2012 · Pharmacology & Therapeutics
  39. The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development
    Heidi C. Meyer, Francis S. Lee, Dylan G. Gee · 2017 · Neuropsychopharmacology
  40. Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation
    Javier Palazuelos, Tania Aguado, Ainara Egia, Raphael Mechoulam, Manuel Guzmán, Ismael Galve‐Roperh · 2006 · The FASEB Journal
  41. The endocannabinoid system: emotion, learning and addiction
    Fabrício A. Moreira, Beat Lutz · 2008 · Addiction Biology
  42. Active endocannabinoids are secreted on extracellular membrane vesicles
    Gabrielli, Martina, Battista, Natalia, Riganti, Loredana, Prada, Ilaria, Antonucci, Flavia, Cantone, Laura, Matteoli, Michela, Maccarrone, Mauro, Verderio, Claudia · 2015 · The EMBO Reports
  43. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
    Pacher, P, Haskó, G · 2008 · British Journal of Pharmacology
  44. Aberrant cannabinoid signaling impairs oviductal transport of embryos
    Haibin Wang, Yong Xia Guo, Dingzhi Wang, Philip J. Kingsley, Lawrence J. Marnett, Sanjoy Das, Raymond N. DuBois, Sudhansu K. Dey · 2004 · Nature Medicine
  45. High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients
    Antonio Pisani, Filomena Fezza, Salvatore Galati, Natalia Battista, Simone Napolitano, Alessandro Finazzi‐Agrò, Giorgio Bernardi, Livia Brusa, Mariangela Pierantozzi, Paolo Stanzione et al. · 2005 · Annals of Neurology
  46. Endocannabinoid mechanisms of pain modulation
    Andrea G. Hohmann, Richard L. Suplita · 2006 · The AAPS Journal
  47. The Science of Marijuana
    Leslie Lars Iversen · 2007 · Oxford University Press eBooks
  48. Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
    Scavone, J.L., Sterling, R.C., Van Bockstaele, E.J. · 2013 · Neuroscience
  49. Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
    Gorzalka, Boris B., Hill, Matthew N., Hillard, Cecilia J. · 2008 · Neuroscience & Biobehavioral Reviews
  50. Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells
    Monica Bari, Natalia Battista, Filomena Fezza, Alessandro Finazzi‐Agrò, Mauro Maccarrone · 2005 · Journal of Biological Chemistry
  51. Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
    Patricia H. Reggio · 2010 · Current Medicinal Chemistry
  52. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
    Moreira, Fabrício A., Aguiar, Daniele C., Guimarães, Francisco S. · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  53. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
    Centonze, D., Bari, M., Rossi, S., Prosperetti, C., Furlan, R., Fezza, F., De Chiara, V., Battistini, L., Bernardi, G., Bernardini, S. et al. · 2007 · Brain
  54. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
    Moreira, Fabrício A., Guimarães, Francisco S. · 2005 · European Journal of Pharmacology
  55. Cannabis use in young people: The risk for schizophrenia
    Paola Casadio, Cathy Fernandes, Robin M. Murray, Marta Di Forti · 2011 · Neuroscience & Biobehavioral Reviews
  56. Requirement of Cannabinoid Receptor Type 1 for the Basal Modulation of Hypothalamic-Pituitary-Adrenal Axis Function
    Cota, Daniela, Steiner, Michel-Alexander, Marsicano, Giovanni, Cervino, Cristina, Herman, James P., Grübler, Yvonne, Stalla, Johanna, Pasquali, Renato, Lutz, Beat, Stalla, Günter K. et al. · 2007 · Endocrinology
  57. CB 2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
    Ester Aso, Salvador Juvés, Rafael J. Maldonado, Isidró Ferrer · 2013 · Journal of Alzheimer s Disease
  58. Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?
    Nadia Solowij, Patricia Therese Michie · 2007 · Journal of Psychiatry and Neuroscience
  59. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
    Cristina Blázquez, Anna Chiarlone, Onintza Sagredo, Tania Aguado, María Ruth Pazos, Eva Resel, Javier Palazuelos, Boris Julien, María Salazar‐Roa, Christine Börner et al. · 2010 · Brain
  60. A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
    Dow P. Hurst, Alan M. Grossfield, Diane L. Lynch, Scott E. Feller, Tod D. Romo, Klaus Gawrisch, Michael C. Pitman, Patricia H. Reggio · 2010 · Journal of Biological Chemistry
  61. Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology
    Kjell Fuxé, Daniel J. Marcellino, Alicia Rivera, Zaida Dı́az-Cabiale, Małgorzata Filip, Belén Gago, David C. S. Roberts, Ülo Langel, Susanna Genedani, Luca Ferraro et al. · 2008 · Brain Research Reviews
  62. Neurotransmitters
    Steven E. Hyman · 2005 · Current Biology
  63. Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors
    Kwang‐Mook Jung, Regina A. Mangieri, Christopher J. Stapleton, Janet Kim, Darren Fegley, Matthew Wallace, Ken Mackie, Daniele Piomelli · 2005 · Molecular Pharmacology
  64. Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
    Bernard Pierre Roques, Marie‐Claude Fournié‐Zaluski, Michel Wurm · 2012 · Nature Reviews Drug Discovery
  65. Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders
    Kay Ahn, Douglas S. Johnson, Benjamin F. Cravatt · 2009 · Expert Opinion on Drug Discovery
  66. Lipid signaling: Sleep, synaptic plasticity, and neuroprotection
    Chu Chen, Nicolas Guillermo Bazan · 2005 · Prostaglandins & Other Lipid Mediators
  67. Cyclooxygenase-2 in synaptic signaling
    Yang, Hongwei, Chen, Chu · 2008 · Current Pharmaceutical Design
  68. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
    Keith A. Sharkey, Nissar A. Darmani, Linda A. Parker · 2013 · European Journal of Pharmacology
  69. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures
    Beat Lutz · 2004 · Biochemical Pharmacology
  70. Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
    Sreemanti Basu, Bonnie N. Dittel · 2011 · Immunologic Research
  71. Endocannabinoid signal in the gut controls dietary fat intake
    Nicholas Vincent DiPatrizio, Giuseppe Astarita, Gary J. Schwartz, Xiaosong Li, Daniele Piomelli · 2011 · Proceedings of the National Academy of Sciences
  72. Lasting Impacts of Prenatal Cannabis Exposure and the Role of Endogenous Cannabinoids In the Developing Brain
    Chia‐Shan Wu, Chris P. Jew, Hui‐Chen Lu · 2011 · Future Neurology
  73. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
    Matthew N. Hill, Boris B. Gorzalka · 2005 · Behavioural Pharmacology
  74. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia
    Ferenc Mátyás, Yevgeni Yanovsky, Ken Mackie, Wolfgang Kelsch, Ulrich Misgeld, Tamás F. Freund · 2005 · Neuroscience
  75. Presence of functional cannabinoid receptors in human endocrine pancreas
    Francisco Javier Bermúdez‐Silva, Juan Suárez, Elena Baixerás, Nusret Čobo, Dolores Bautista, Antonio Luis Cuesta-Muñoz, Esther Fuentes, Pablo Juan-Picó, M.J. Castro, Garry Milman et al. · 2007 · Diabetologia
  76. Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats
    Trezza, Viviana, Damsteegt, Ruth, Manduca, Antonia, Petrosino, Stefania, Van Kerkhof, Linda W.M., Pasterkamp, R. Jeroen, Zhou, Yeping, Campolongo, Patrizia, Cuomo, Vincenzo, Di Marzo, Vincenzo et al. · 2012 · The Journal of Neuroscience
  77. Brain regulation of food intake and appetite: molecules and networks
    C. B Roberger · 2005
  78. Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
    Laviolette, S. R., Grace, A. A. · 2006 · Journal of Neuroscience
  79. RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits
    Talia N. Lerner, Anatol C. Kreitzer · 2012 · Neuron
  80. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
    Dagmar Koethe, Ida Cirila Llenos, J. R. Dulay, Carolin Hoyer, Ε. Fuller Torrey, F. Markus Leweke, Serge Weis · 2007 · Journal of Neural Transmission
  81. A fatty gut feeling
    Daniele Piomelli · 2013 · Trends in Endocrinology and Metabolism
  82. Endocannabinoid functions controlling neuronal specification during brain development
    Tibor Harkany, Erik Keimpema, Klaudia Barabás, Jan Mulder · 2008 · Molecular and Cellular Endocrinology
  83. Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization
    Alejandro J. Pernía‐Andrade, Ako Kato, Robert Witschi, Rita Nyilas, István Katona, Tamás F. Freund, Masahiko Watanabe, Jörg Filitz, Wolfgang Koppert, Jürgen Schüttler et al. · 2009 · Science
  84. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
    Bar-Lev Schleider, Lihi, Mechoulam, Raphael, Saban, Naama, Meiri, Gal, Novack, Victor · 2019 · Scientific Reports
  85. A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo
    Ao Dong, Kaikai He, Barna Dudok, Jordan S. Farrell, Wuqiang Guan, Daniel J. Liput, Henry L. Puhl, Ruyi Cai, Huan Wang, Jiali Duan et al. · 2021 · Nature Biotechnology
  86. Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression
    Cristina Blázquez, María Salazar‐Roa, Arkaitz Carracedo, Mar Lorente, Ainara Egia, Luis González‐Feria, Amador Haro, Guillermo Velasco, Manuel Guzmán · 2008 · Cancer Research
  87. (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
    Kelsey C. Duggan, Daniel J. Hermanson, Joel Musee, Jeffery J. Prusakiewicz, Jami L. Scheib, Bruce Douglas Carter, Surajit Banerjee, John A. Oates, Lawrence J. Marnett · 2011 · Nature Chemical Biology
  88. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
    Maccarrone, Mauro, Di Marzo, Vincenzo, Gertsch, Jürg, Grether, Uwe, Howlett, Allyn C., Hua, Tian, Makriyannis, Alexandros, Piomelli, Daniele, Ueda, Natsuo, van der Stelt, Mario · 2023 · Pharmacological Reviews
  89. Exercise-induced endocannabinoid signaling is modulated by intensity
    Raichlen, David A., Foster, Adam D., Seillier, Alexandre, Giuffrida, Andrea, Gerdeman, Gregory L. · 2013 · European Journal of Applied Physiology
  90. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats
    Resstel, Leonardo B.M., Joca, Sâmia R.L., Moreira, Fabrício A., Corrêa, Fernando M.A., Guimarães, Francisco S. · 2006 · Behavioural Brain Research
  91. Biology of endocannabinoid synthesis system
    Jun Wang, Natsuo Ueda · 2008 · Prostaglandins & Other Lipid Mediators
  92. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
    Antonia Serrano, Loren H. Parsons · 2011 · Pharmacology & Therapeutics
  93. Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
    Fabrício A. Pamplona, Juliano Ferreira, Octávio Menezes de Lima, Filipe Silveira Duarte, Allisson Freire Bento, Stefânia Forner, Jardel Gomes Villarinho, Luigi Bellocchio, Carsten Tobias Wotjak, Raissa Lerner et al. · 2012 · Proceedings of the National Academy of Sciences
  94. Endocannabinoids in the retina: From marijuana to neuroprotection
    Stephen Yazulla · 2008 · Progress in Retinal and Eye Research
  95. Cannabinoids and anxiety
    Moreira, Fabrício A., Wotjak, Carsten T. · 2009 · Current topics in behavioral neurosciences
  96. Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons
    Elisa L. Hill‐Yardin, Thierry Gallopin, Isabelle Férézou, Bruno Cauli, Jean Rossier, Paul Schweitzer, Bertrand Lambolez · 2007 · Journal of Neurophysiology
  97. Lipids in Psychiatric Disorders and Preventive Medicine
    Schneider, Miriam, Levant, Beth, Reichel, Martin, Gulbins, Erich, Kornhuber, Johannes, Müller, Christian P. · 2017 · Neuroscience & Biobehavioral Reviews
  98. Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)
    Dina Navia‐Paldanius, Juha R. Savinainen, Jarmo T. Laitinen · 2012 · Journal of Lipid Research
  99. Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems
    Marcello Solinas, Steven R. Goldberg · 2005 · Neuropsychopharmacology
  100. Polymodal activation of the endocannabinoid system in the extended amygdala
    Puente, Nagore, Cui, Yihui, Lassalle, Olivier, Lafourcade, Mathieu, Georges, François, Venance, Laurent, Grandes, Pedro, Manzoni, Olivier J · 2011 · Nature Neuroscience